Current controversies in the treatment of stage I seminoma center on the relative roles of surveillance, adjuvant radiotherapy (RT), and adjuvant single-agent chemotherapy. Surveillance has been studied in over 800 patients,
Matthew Ballo, MD
Advertisement
Articles by Matthew Ballo, MD
Advertisement
Latest Updated Articles
- Controversies in the Management of Stage I Seminoma
Published: August 1st 1998 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Neoadjuvant Pembrolizumab/Radiotherapy Earns EU Approval in HNSCC Group
2
Pembrolizumab/Belzutifan Improves DFS in ccRCC Following Nephrectomy
3
3 Things You Should Know About Single-Agent ADCs in TNBC Treatment
4
ZEN-3694 Earns FDA Orphan Drug Designation in NUT Carcinoma
5
